1978-Effect of motilin antiserum infusion on porcine IDMCS .pdf

 

1971- Inflammatory response in chemical injury of liver Proc Soc Aust Exp pathologists.PDF
1978-Effect of motilin antiserum infusion on porcine IDMCS.pdf
1978-Mechanisms of motilin release by metoclopramide.pdf
1979-Chlorbutol toxicity and dependence Med J Aust vol 1 issue 7 p288.PDF
1980-Effect of motilin antiserum infusion on porcine IDMCS.pdf
1980-Effect of renal function and age on plasma motilin and pancreatic polypeptide PP.pdf
1980-In vitro release of motilin from human duodenal mucosa.pdf
1980-Mechanisms of motilin release by metoclopramide.pdf
1980-Plasma cholecystokinin.pdf
1980-Radioimmunoassay of cholecystokinin in human plasma, Clin Chim Acta Vol. 111, issue 1 p81-9.pdf
1980-Release of Motilin by Metoclopramide.pdf
1981-Cholecystokinin and gallbladder emptying in normal subjects and patients with gallstones.pdf
1981-Effects of food ingestion on plasma bombesin.pdf
1981-Immunoneutralization of motilin, Horm Metab Res vol 13 issue 8 p470-1.pdf
1981-Migrating myoelectric complexes and motilin in the dog.pdf
1981-Motilin and migrating myoelectric complexes in pigs, J Physiol 310; 37-8.pdf
1981-Motilin and migrating myoelectric complexes in pigs.pdf
1981-Myasthenia gravis in melanesians in the Solomon islands, P N G Med J vol 24, issue 1 p50-3.pdf
1981-Plasma cholecystokinin and the migrating myoelectric complex in man.pdf
1981-Radioimmunoassay of cholecystokinin in human plasma, Clin Chim Acta Vol. 111, issue 1 p81-9.pdf
1982-Cholecystokinin and gallbladder contraction - effect of CCK infusion, Peptides vol 2, suppl 2 p259-62.pdf
1982-Cholecystokinin secretion and gall bladder function in patients with Coeliac Disease.pdf
1982-Compliance diagnostic results and costs in a large bowel screening programme.PDF
1982-Plasma cholecystokinin, motilin and pancreatic polypeptide, and the migrating myoelectric complex in man.pdf
1982-Relation of plasma cholecystokinin and motilin to gallbladder contraction in man.pdf
1982-Release of cholecystokinin.pdf
1983-Atropine suppression test for pancreatic polypeptide secreting tumors.pdf
1983-Cholecystokinin release by magnesium sulphate.pdf
1983-Cholecystokinin secretion and gallbladder contraction in patients with celiac sprue.PDF
1983-Gallstone dissolution - a comparison of solvents for direct biliary perfusion.pdf
1983-Is cholecystokinin the physiological stimulus releasing pancreatic polypeptide in man.pdf
1983-Is circulating cholecystokinin a physiological stimulus for pancreatic polypeptide release in man.pdf
1983-Methyl tertiary butyl ether rapidly dissolves gallstones in vitro and in vivo.pdf
1983-Motility of the ileocolonic region in healthy man.pdf
1983-Release of cholecystokinin by bombesin and gastrin releasing peptide.pdf
1983-Small intestinal motility and hormones in the irritable bowel syndrome.PDF
1984- Methyl tertiary-butyl ether MTBE in expired air and methanol in blood do not reach potentially harmful levels.PDF
1984-Effects of morphine on intestinal motility and transit - studies in distal ileum and ileocolonic junction of healthy man.pdf
1984-Migrating motor complexes fade out in the human terminal ileum.pdf
1984-Molecular forms of CCK in human postprandial plasma.pdf
1984-Motilin and migrating myoelectric complexes in the pig and the dog.pdf
1984-Motilitat am ileokolischen ubergang des menschen - German version.pdf
1984-Motility of the terminal ileum and ileocecal sphincter in healthy humans, Gastroenterology vol 87, issue 4 p857-66.pdf
1984-Rapid gallstone dissolution in dogs using methyl tertiary-butyl ether and an aspiration-infusion pump.pdf
1984-Small intestinal motor patterns after ileoanal anastomosis.pdf
1984-The migrating motor complex - its relation to circulating CCK motilin and pancreatic polypeptide in irritable bowel patients and in controls.PDF
1985-Antidiarrhoeische mechanismen im ileum. Opiat und anticholinergika wirkungen - German version.pdf
1985-Antidiarrhoeische mechanismenin ileum. Opiat und anticholinergika wirkungen - German version.pdf
1985-Cholelitholysis using methyl tertiary butyl ether, Gastroenterology, vol 88, issue 1, pt 1 p122-5.pdf
1985-Dissolution of cholesterol gallstones in the gallbladder and bile ducts in humans using methyl tertiary-butyl ether.pdf
1985-Effects of morphine and atropine on motility and transit in the human ileum.pdf
1985-Effects of morphine atropine and naloxone on the human ileocaecal sphincter.pdf
1985-Effects of morphine on motility and transit in human small intestine.pdf
1985-In-vitro dissolution of cholesterol gallstones.pdf
1985-Is gallstone dissolution practical.pdf
1985-Motilitat am ileokolischen ubergang des menschen - German version.pdf
1985-Motility of the small intestine after proctocolectomy and ileal pouch-anal anastomosis.pdf
1985-Rapid dissolution of gallstones by methyl tert-butyl ether.pdf
1985-The migrating motor complex - distribution along the human bowel.pdf
1985-Validation of sulfapyridine appearance in blood as a measure of small bowel transit.pdf
1986-Campylobacter pyloridis infection as possible complication of weight loss therapy.pdf
1986-Gallstones - what can be done and when to recommend it.pdf
1986-Human interdigestive motility - variations in patterns from esophagus to colon.pdf
1986-Incidence of Campylobacter pyloridis gastritis in AIDS and other immunosuppressed patients.pdf
1986-Initial experience with methyl tertiary butyl ether cholelitholysis.pdf
1986-Rapid detection of Campylobacter pyloridis on the gastric mucosa and its association with gastritis.pdf
1986-Sulfapyridine appearance in plasma after salicylazosulfapyridine.pdf
1987-Campylobacter pyloridis gastritis I - Detection of urease as a marker of bacterial colonization and gastritis, Am J Gastroenterol, vol 82, issue 4 p292-6.pdf
1987-Campylobacter Pyloridis Gastritis II-Distribution of bacteria and associated inflammation in the gastroduodenal environment.pdf
1987-Campylobacter, gastritis and ulceration.pdf
1987-Do Campylobacter pyloridis and gastric metaplasia have a role in duodenal ulceration.pdf
1987-Double blind trial of de-nol in non-ulcer dyspepcia associated with Campylobacter pyloridis gastritis.pdf
1987-Dyspeptic symptoms improve following eradication of gastric Campylobacter pyloridis.pdf
1987-Evaluation of the danish gastric balloon in the treatment of obesity.PDF
1987-Gallstones optimal diagnostic techniques.pdf
1987-Initial experience with pneumogastroplasty in obese patients.pdf
1987-Methyl tertiary butyl ether cholelitholysis of calculi in the gallbladder and bile ducts.pdf
1987-Pneumogastroplasty in the obese using the Danish Ballobes gastric balloon.pdf
1987-Relationship of patient's country of origin to endoscopic frequency of Campylobacter pyloridis gastritis.pdf
1987-Side-effects and complications in 110 consecutive patients with the danish Ballobes gastric balloon.PDF
1987-Symptoms improve after the eradication of gastric Campylobacter pyloridis MJA.PDF
1987-The incidence of C pyloridis gastritis in healthy volunteers.pdf
1988-Complications and side effects of Ballobes intrgastric balloon in 427 patients, International Ballobes Symposium Stockholm.pdf
1988-Double blind study of Ballobes intragastric balloon without diet or behaviour modification.pdf
1988-Long term Campylobacter pylori recurrence post eradication.pdf
1988-The role of campylobacter pylori and gastric metaplasia in duodenal ulceration.pdf
1988-The use of serology to diagnose active Campylobacter pylori infection.pdf
1989-Bowel-flora alteration - a potential cure for inflammatory bowel disease and irritable bowel syndrome.pdf
1989-C pylori related non ulcer dyspepsia improves after c pylori eradication.PDF
1989-Duodenal ulcer recurrence in patients remaining c pylori negative long term post eradication.PDF
1989-Long term Campylobacter pylori recurrence following apparent eradication.pdf
1989-Oral vancomycin can reverse idiopathic constipation.PDF
1989-Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication.pdf
1989-Triple therapy of c pylori can reverse hypochlorhydria.PDF
1990-Cure of duodenal ulcer after eradication of Helicobacter pylori.pdf
1990-Endoscopic diagnosis of Helicobacter pylori HP - approaching the Gold Standard.pdf
1990-How common are duodenal ulcers negative for Helicobacter pylori.pdf
1990-Is doxycycline more effective that tetracycline HCL in triple therapy of Helicobacter pylori.pdf
1990-Triple therapy for Helicobacter pylori eradication - 2 or 4 weeks.pdf
1990-Who needs maintenance H2RA's after duodenal ulcer cure.pdf
1991-Adverse effects of Triple therapy. Recent Advancesin Chemotherapy proceedings of the 17th International Congress of Chemotherapy.PDF
1991-Economic impact of duodenal ulcer cure using triple therapy in the US.pdf
1991-Helicobacter pylori - negative duodenal ulcer.pdf
1991-Side effects of triple Therapy.PDF
1991-Use of 5-amino salicylic acid in irritable bowel syndrome.pdf
1992-Chronic constipation reversed by restoration of bowel flora - a case and a hypothesis.PDF
1992-Frequent early extracorporeal shock wave lithotripsy and simvastatin accelerate gallbladder fragment clearance.PDF
1992-Helicobacter pylori - negative gastric ulcer.pdf
1992-Helicobacter pylori eradication failure - further treatment possibilities.pdf
1992-Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.pdf
1992-Helicobacter pylori reinfection 4 years post-eradication.pdf
1992-High efficacy low dose triple therapy for Helicobacter pylori.pdf
1992-Laproscopic vagotomy for chronic duodenal ulcer.PDF
1992-Oxygenating mouthguard alleviates hypoxia during gastroscopy.pdf
1992-Panel discussion - Short-term and long-term consequences of gastritis and duodenitis.PDF
1992-Possibilities for Helicobacter pylori suppression-eradication.pdf
1992-Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication.pdf
1993-Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori.pdf
1993-Does H pylori play a role in esophageal reflux.pdf
1993-H pylori eradication side effects compliance - 14 days vs 12 day triple therapy.pdf
1993-letters to the editor - Supplemental oxygen therapy during endoscopy and recovery.PDF
1993-Putting back the bugs - bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome.PDF
1993-Relevance of in-vitro metronidazole resistance to H pylori eradication and eradication failure.pdf
1994-Chronic constipation may be reversed by Bacteriotherapy.PDF
1994-Eradication of H pylori in dyspeptic patients with prior DU surgery.pdf
1994-Failure to use combined tests may miss Helicobacter pylori diagnosis.pdf
1994-Features of patients who fail all attempts at Helicobacter pylori eradication.pdf
1994-Helicobacter infection - the current state of play.pdf
1994-Helicobacter pylori reinfection rate in patients with cured duodenal ulcer.pdf
1994-Intestinal metaplasia - occurrence in Korean vs matched Australian patients with H. pylori gastritis.pdf
1994-Methods of oxygen delivery during upper gastrointestinal endoscopy.pdf
1994-Non-ulcer dyspepsia sub-groups and therapy for Helicobacter pylori.pdf
1994-Optimal H pylori therapy - a combination of omeprazole and triple therapy.pdf
1994-Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.pdf
1995-7 day therapy for helicobacter pylori.pdf
1995-Bacteriotherapy for chronic constipation - a long term follow-up.PDF
1995-Bacteriotherapy for chronic fatigue syndrome a long term follow-up study.pdf
1995-Dyspepsia - What would you do.PDF
1995-Eradication of Helicobacter pylori may not reverse severe gastric dyspepsia.pdf
1995-Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.PDF
1996-Eradicating Hpylori - are we winning the battle.pdf
1996-Eradication failure after Hpylori treatment - further therapies.pdf
1996-Evaluation of whole blood antibody kit to detect active Helicobacter pylori infection.pdf
1996-from intestinal metaplasia to gastric cancer - whither surveillance.PDF
1996-Gastro-oesophageal reflux disease.pdf
1996-Occult Hpylori infection - detection & treatment Gastroenterology.pdf
1996-Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens.pdf
1996-What is the optimal therapy for Helicobacter pylori eradication - English version.pdf
1996-What is the optimal therapy for Helicobacter pylori eradication - Russian version.pdf
1997-A cost analysis of different Test and Treat strategies for the management of patients on maintenance therapy for Peptic ulcer disease.pdf
1997-A man with dyspepsia.pdf
1997-Gastro-oesophageal reflux disease.pdf
1997-Letters to the editor - RE W de Boer - Gastric outlet obstruction and Helicobacter pylori.pdf
1997-Modification of the colonic microflora using probiotics - the way forward.pdf
1997-The use of probiotic therapy as a novel approach to the management of irritable bowel syndrome - a preliminary study.pdf
1998 - Eradication therapies for H Pylori Symposium 2-3 Abstract.PDF
1998 - Toward monotherapy for Hpylori infection - first results with a single triple capsule Basic Mechanisms to clinical cure.pdf
1998-Eradication of Hpylori using pantoprazole quad therapy in routine consultant practice.pdf
1998-Eradication therapies for Hpylori.pdf
1998-Helicobacter pylori eradication failure - 'salvage' therapies needed.pdf
1998-In vitro helicobacter pylori resistance to metronidazole and clarithromycin in an Australian population.pdf
1998-Modified clarithromycin-quad therapy as 'salvage' treatment for H pylori eradication failure.pdf
1998-Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Hpylori infection.pdf
1998-Treatment of severe Crohns disease CD using Rifabutin-Macrolide-Clofazimine combination.pdf
1999-Macroscopic colitis - a separate entity.pdf
1999-Symptom impovement in Helicobacter pylori positive non-ulcer dyspeptic patients after treatment with the carotenoid astaxanthin.pdf
2000-A high level of primary resistance to metronidazole and clarithrycin in previously untreated symptomatic patients presenting for endoscopy in australia.pdf
2000-Circulating T-Cell response to Helicobacter pylori infection in Chronic Gastritis.pdf
2000-Flora Power - fecal bacteria cure chronic C.difficile diarrhea.pdf
2000-Helicobacter pylori pandemic - the evolving concepts.pdf
2000-Quadruple should be first-line therapy for Helicobacter pylori infection..pdf
2000-Treatment failures and secondary resistance to antibiotics. A growing concern in H pylori therapy.pdf
2000-Treatment of severe Crohns disease using rifabutin-macrolide-clofazimine combination - results at 30-37 months.PDF
2000-Treatment of severe Crohns disease using rifabutin-macrolide-clofazimine combination - results at 38-43 months.PDF
2001-Direct antibiotic susceptibility testing of helicobacter pylori - does it have a role.pdf
2001-Gastric carcinoma - T-cell response and vascurarity.PDF
2001-Response to Drs Famularo et al.pdf
2001-Shift of the gastric T-cell response in gastric carcinoma.pdf
2001-Skewered diverticulum - another cause of abdominal pain.PDF
2001-Treatment of chronic constipation and colitis using human probiotic infusions.pdf
2002-Eradication of Dientamoeba fragilis can reslove IBS-like symptoms.PDF
2002-Impaired host immunity contributes to Helicobacter pylori eradication failure.pdf
2002-Irritable bowel syndrome and dientamoeba fragilis.PDF
2002-Laparoscopic excision of a Brunners gland hamartoma of the duodenum.PDF
2002-Rifabutin - key to H pylori rescue therapy.pdf
2002-Treatment of severe Crohns disease using antimycobacterial triple therapy - approaching a cure.PDF
2002-Varying gastric sensitivities of H pylori.pdf
2003-Can the response to eradication therapy in Helicobacter pylori infection be predicted.pdf
2003-Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of HP.pdf
2003-Faecal bacteriotherapy for chronic C-difficile syndrome.pdf
2003-Lactoferrin - milking ulcers.pdf
2003-Treatment of Ulcerative colitis using fecal bacteriotherapy.pdf
2004-Bacteriotherapy using fecal flora - toying with human motions.pdf
2004-Dientamoeba fragilis and Irritable bowel syndrome.PDF
2004-Meta-analysis - the efficacy adverse events and adherence related to first-line anti-Helicobacter pylori quadruple therapies.pdf
2004-Novel appearance of healing mucosa following antimycobacterium avium paratuberculosis for Crohns disease.pdf
2004-Use of hyperlac in coeliac disease and its effect on disaccharidase deficiency.PDF
2005-Anti-MAP therapy in the treatment of active crohns disease.pdf
2005-anti-MAP therapy induces and maintains remission in severe crohns disease.PDF
2005-Effects of supplemental oxygen during endoscopy.pdf
2005-Evaluation of anti-Helicobacter pylori IgG2 antibody for the diagnosis of HP infection in western and chinese populations.pdf
2005-How effective are quadruple therapies as first-line H.pylori eradication therapies.pdf
2005-Probiotics under the regulatory microscope.pdf
2005-Selective reduction of anti-Helicobacter pylori IgG subclass antibody in gastric carcinoma.pdf
2006 Borody - Anti MAP therapy and fistula closure in patients with severe crohns.pdf
2006 -Fecal bacteriotherapy in the treatment of recurrent C difficile infection.PDF
2006-Anti-Mycobacterium avium SS Paratuberculosis (MAP) therapy and fistula Closure in patients with Severe Crohn's Disease.pdf
2006-Australian Anti-map trials, Microbial-host interactions workshop..pdf
2006-Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant H pylori infection.pdf
2006-Investigating the tolerability of four bowel preparations - the taste test.PDF
2006-Severe recurrent Crohns disease of ileocolonic anastomosis and antimicrobial - anti-mycobacterial - therapy.pdf
2007- Fecal bacteriotherapy - an effective treatment for relapsing symptomatic clostridium dificile infection. UEGW 2007 abstract.pdf
2007- Fecal bacteriotherapy - an effective treatment for relapsing symptomatic clostridium dificile infection. UEGW.pdf
2007- Use of combination therapy as first line and salvage therapy in parasite infections. UEGW.pdf
2007-Anti-mycobacterial therapy in Crohns disease heals mucosa with longitudinal scars.PDF
2007-Long-term anti-MAP therapy in crohns disease - adverse effects are mild, Thomas J Borody, UEGF.pdf
2007-MAP associated Crohns disease MAP Kochs postulates - causality and Crohns disease.pdf
2007-Use of combination therapy as first line and salvage therapy in parasite infections.pdf
2008 Phagocyte-Specific S100 Proteins are Activators of Pattern Recognition Receptors and Released During Active IBD.pdf
2008-Clostridium difficile complicating inflammatory bowel disease - Pre and Post treatment findings,Thomas J Borody et al.pdf
2008-Mucosal release of phagocyte-specific S100 proteins is strongly enhanced during active inflammatory bowel disease.pdf
2008-Phagocyte-specific S100 proteins are released from affected mucosa and promote immune response during inflammatory bowel disease.pdf
2008-Rapid and superior diagnosis of Hpylori infection by 14C Urea Heliprobe test versus the PYtest.pdf
2008-Selective Th2 pattern of cytokine secretion in Mycobacterium avium subsp paratuberculosis infected Crohns disease.pdf
2008-Years continuous anti-MAP therapy for crohns - observation of side effects.pdf
2009-Anti-MAP rescues anti-TNF failures for over 4 years, Thomas J Borody et al, Gastroenterol, 136(suppl 1) W1222.pdf
2009-C.diff complicating Inflammatory Bowel Disease Cure after Fecal Bacteriotherapy DDW Poster.pdf
2009-Changes in crohns disease activity index and c-reactive protein levels during Anti-Map therapy.PDF
2009-Colchicine plus Olsalazine for treatment of constipation-predominant irritable bowel syndrome.pdf
2009-Enema Intra-Colonic infusion.pdf
2009-Entamoeba histolytica - another cause of crohns disease.PDF
2009-Is the infected patient too Difficile to treat.pdf
2009-Novel intra-colonic infusion of three anti-parasite agents for resistant Bh infections. UEGW 2010 ABSTRACT.pdf
2009-Novel intra-colonic infusion of three anti-parasite agents for resistant blastocystis hominis infections.PDF
2009-Novel intra-colonic infusion of three anti-parasite agents for resistant Blastocystis hominis ionfection.pdf
2009-Treatment of severe constipation improves parkinsons disease symptoms.PDF
2010- Comparison of a novel solid urease test vs Pronto Dry - UEGW 2010 ABSTRACT.pdf
2010-Durable alteration of the colonic microbiota by the administration of donor fecal flora.PDF
2010-Fecal bacteriotherapy - fecal transplant and the microbiome.PDF
2010-Fecal bacteriotherapy in the treatment of recurrent C difficile infection.PDF
2011- Fecal microbiota transplantation- current status and future directions.pdf
2011- FMT in UC Spotlight on patient's E'motions, TJ Borody, Jordana Campbell, Expert Reviews.pdf
2011- Myoclonus-dystonia affected by GI Microbiota.pdf
2011-Borody.Khoruts -FMT Emerging Applications.pdf
2011-Endoscopic Fecal Microbiota Transplantation_First line treatment for severe C diff infection.pdf
2011-Fecal microbiota transplantation (FMT) in Multiple Sclerosis (MS) American College of Gastroenterology p111.pdf
2011-Fecal microbiota Transplantation and emerging applications, TJ Borody and A. Khoruts.pdf
2011-Intra-colonic infusion of anti-parasite agents for resistant Blastocystis hominis Long term folow up.pdf
2011-Primary treatment of Crohn's disease combined antibiotics taking centre stage.pdf
2011-Reversal of Idiopathic Thrombocytopenic Purpura (ITP) with fecal microbiota transplantation (FMT).pdf
2011-Treating Clostridium difficile infection with fecal microbiota transplantation, Fecal microbiota transplantation Workgroup, Clin Gastroenterol and Hep.pdf
2012- Fecal microbiota transplantation in ulceative colitis - review of 24 years experience.pdf
2012- Fecal microbiota transplantation- techniques, applications and issues.pdf
2012-Bacteriotherapy in chronic fatigue syndrome (CFS)- a retrospective review.pdf
2012-Diagnostic value of fundic red spots in Helicobacter pylori.pdf
2012-Mycobacterium avium ss paratuberculosis-associated Diseases Piecing the Crohn's Puzzle together.pdf
2012-rescue H pylori therapy in the clinical setting.pdf
2012-Resistant fistulising Crohn's disease treated with combination of infliximab, anti-MAP and HBO.pdf
2012-Single transcolonoscopic infusion of three anti-protozoal agents for difficult Bh infections. UEGW ABSTRACT 2012.pdf
2012-The many faces of Crohn's Disease Latest concepts in etiology.pdf
2013 - Fecal Microbiota Transplantation a new standard treatment option for Clostridium difficile infection.pdf
2013 - The GI microbiome and its role in CFS - ACNEM paper.pdf

CDD